Two scans to study prostate cancer in the same group
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This trial looks at prostate cancer patients who have not started treatment yet and have two different PET/CT scans close together. It may help doctors compare how these scans show prostate cancer in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed (biopsy/pathology) prostate cancer and have not started treatment yet
- You can get two PET/CT scans (68Ga-PSMA-11 and 68Ga-P16-093) within one week
- You are able to sign written consent to join the study
- You do not have a known allergy to PSMA scan dye/medicine
- Your medical conditions are not expected to interfere with following the study schedule
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well two different PSMA PET scans work for men with advanced prostate cancer. The scans help doctors see where the cancer is, which can guide treatment decisions and help you and your doctor plan next steps.
This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.
This study compares two types of PET/CT scans (using different radioactive tracers) to see which one is better at finding prostate cancer, detecting if it has come back, or spotting spread to other parts of the body. You will get both scans so doctors can compare them directly.
This study tests a new type of PET scan (a detailed imaging test) to find out if prostate cancer has come back after treatment. You'll receive an injection of a special tracer and then have a scan that takes pictures to help doctors locate any cancer.
This study compares two types of scans, a PSMA PET/CT and a regular CT, to see which one better detects prostate cancer spread. If you join, you'll get both scans and the results may help guide your treatment.
This research study tests a new imaging scan (called 68Ga-OncoACP3-PET/CT) to help find prostate cancer and see where it may have spread. The scan uses a radioactive tracer to help doctors visualize cancer cells and decide on the best treatment options.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.